These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 23050819

  • 1. Cardiac repair with thymosin β4 and cardiac reprogramming factors.
    Srivastava D, Ieda M, Fu J, Qian L.
    Ann N Y Acad Sci; 2012 Oct; 1270():66-72. PubMed ID: 23050819
    [Abstract] [Full Text] [Related]

  • 2. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.
    Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D.
    Nature; 2004 Nov 25; 432(7016):466-72. PubMed ID: 15565145
    [Abstract] [Full Text] [Related]

  • 3. Thymosin beta4 is cardioprotective after myocardial infarction.
    Srivastava D, Saxena A, Michael Dimaio J, Bock-Marquette I.
    Ann N Y Acad Sci; 2007 Sep 25; 1112():161-70. PubMed ID: 17600280
    [Abstract] [Full Text] [Related]

  • 4. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.
    Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D.
    Nature; 2012 May 31; 485(7400):593-8. PubMed ID: 22522929
    [Abstract] [Full Text] [Related]

  • 5. Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart.
    Bollini S, Riley PR, Smart N.
    Expert Opin Biol Ther; 2015 May 31; 15 Suppl 1():S163-74. PubMed ID: 26094634
    [Abstract] [Full Text] [Related]

  • 6. Thymosin beta4 and cardiac repair.
    Shrivastava S, Srivastava D, Olson EN, DiMaio JM, Bock-Marquette I.
    Ann N Y Acad Sci; 2010 Apr 31; 1194():87-96. PubMed ID: 20536454
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
    Cavasin MA.
    Am J Cardiovasc Drugs; 2006 Apr 31; 6(5):305-11. PubMed ID: 17083265
    [Abstract] [Full Text] [Related]

  • 8. C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair.
    Hinkel R, Ball HL, DiMaio JM, Shrivastava S, Thatcher JE, Singh AN, Sun X, Faskerti G, Olson EN, Kupatt C, Bock-Marquette I.
    J Mol Cell Cardiol; 2015 Oct 31; 87():113-25. PubMed ID: 26255251
    [Abstract] [Full Text] [Related]

  • 9. Thymosin β4-mediated protective effects in the heart.
    Hinkel R, Klett K, Bähr A, Kupatt C.
    Expert Opin Biol Ther; 2018 Jul 31; 18(sup1):121-129. PubMed ID: 30063857
    [Abstract] [Full Text] [Related]

  • 10. Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection.
    Hinkel R, Trenkwalder T, Kupatt C.
    Ann N Y Acad Sci; 2012 Oct 31; 1269():102-9. PubMed ID: 23045977
    [Abstract] [Full Text] [Related]

  • 11. Thymosin β4 released from functionalized self-assembling peptide activates epicardium and enhances repair of infarcted myocardium.
    Wang YL, Yu SN, Shen HR, Wang HJ, Wu XP, Wang QL, Zhou B, Tan YZ.
    Theranostics; 2021 Oct 31; 11(9):4262-4280. PubMed ID: 33754060
    [Abstract] [Full Text] [Related]

  • 12. Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming.
    Mohamed TM, Stone NR, Berry EC, Radzinsky E, Huang Y, Pratt K, Ang YS, Yu P, Wang H, Tang S, Magnitsky S, Ding S, Ivey KN, Srivastava D.
    Circulation; 2017 Mar 07; 135(10):978-995. PubMed ID: 27834668
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic potential of thymosin β4 in myocardial infarct and heart failure.
    Stark C, Taimen P, Tarkia M, Pärkkä J, Saraste A, Alastalo TP, Savunen T, Koskenvuo J.
    Ann N Y Acad Sci; 2012 Oct 07; 1269():117-24. PubMed ID: 23045979
    [Abstract] [Full Text] [Related]

  • 14. No muscle for a damaged heart: thymosin beta 4 treatment after myocardial infarction does not induce myocardial differentiation of epicardial cells.
    Kispert A.
    J Mol Cell Cardiol; 2012 Jan 07; 52(1):10-2. PubMed ID: 22019445
    [No Abstract] [Full Text] [Related]

  • 15. Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction.
    Chiu LL, Reis LA, Momen A, Radisic M.
    Regen Med; 2012 Jul 07; 7(4):523-33. PubMed ID: 22817626
    [Abstract] [Full Text] [Related]

  • 16. Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart.
    Smart N, Risebro CA, Clark JE, Ehler E, Miquerol L, Rossdeutsch A, Marber MS, Riley PR.
    Ann N Y Acad Sci; 2010 Apr 07; 1194():97-104. PubMed ID: 20536455
    [Abstract] [Full Text] [Related]

  • 17. Thymosin β4 and cardiac regeneration: are we missing a beat?
    Gajzer DC, Balbin J, Chaudhry HW.
    Stem Cell Rev Rep; 2013 Jun 07; 9(3):303-12. PubMed ID: 22628110
    [Abstract] [Full Text] [Related]

  • 18. Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction.
    Peng H, Xu J, Yang XP, Dai X, Peterson EL, Carretero OA, Rhaleb NE.
    Am J Physiol Heart Circ Physiol; 2014 Sep 01; 307(5):H741-51. PubMed ID: 25015963
    [Abstract] [Full Text] [Related]

  • 19. The role of thymosin-β4 in kidney disease.
    Vasilopoulou E, Winyard PJ, Riley PR, Long DA.
    Expert Opin Biol Ther; 2015 Sep 01; 15 Suppl 1():S187-90. PubMed ID: 26096077
    [Abstract] [Full Text] [Related]

  • 20. Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart.
    Smart N, Bollini S, Dubé KN, Vieira JM, Zhou B, Riegler J, Price AN, Lythgoe MF, Davidson S, Yellon D, Pu WT, Riley PR.
    Ann N Y Acad Sci; 2012 Oct 01; 1269():92-101. PubMed ID: 23045976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.